Delivery Order SPE2DR25D1053-SPE2DR26FV514
Award Date 1/14/26
Potential Completion Date 1/15/26
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,552.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,732.50 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml), a medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price, competitively awarded delivery order, with performance to be completed by January 14, 2026, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was issued under no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Quillivant XR 25 mg/5 mL suspension in a 180 mL quantity, valued at $4,878.91 with a firm fixed-price structure. This non-set-aside award was issued under a competitive process and is performable in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. The contract represents a task order execution under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,615.95 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (150 ml), with delivery scheduled for completion by January 9, 2026. The award was made on January 8, 2026, using firm fixed-price pricing with no set-aside designation, indicating competitive procurement. The product will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, valued at $1,807.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by June 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, valued at $2,638.27. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a delivery order, with an ultimate completion date of November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $1,473.16 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 12, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 120 mL quantities, with a ceiling value of $6,424.45. This competitively awarded, firm fixed-price contract is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 60 ml quantity. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,526.88 and is scheduled for completion by October 27, 2025. The contract was issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999...